Body / Physical

THC and Exercise: What Happens When You Work Out High

By RethinkTHC Research Team|15 min read|March 5, 2026

Body / Physical

More Enjoyment

A 2019 Frontiers in Public Health study found most cannabis-using exercisers in legal states use shortly before or after workouts, reporting greater enjoyment — but THC adds 20-50 BPM to heart rate.

YorkWilliams et al., Frontiers in Public Health, 2019

YorkWilliams et al., Frontiers in Public Health, 2019

Infographic showing cannabis users report more exercise enjoyment but with 20 to 50 BPM heart rate increaseView as image

The idea of working out high is not new. Cannabis has been part of athletic subcultures for decades, from long-distance runners to martial artists to weekend gym-goers who find that a small dose before lifting makes the experience more enjoyable. A 2019 study published in Frontiers in Public Health found that the majority of cannabis users in legal states who also exercise reported using cannabis shortly before or after physical activity. Many said it increased enjoyment and aided recovery.

But the gap between user reports and controlled research is wide. The science of cannabis and exercise sits at the intersection of two complex systems: exercise physiology and the endocannabinoid system. Understanding what actually happens when you work out high requires pulling apart those systems and examining where they overlap, where they conflict, and where we simply do not have enough data to draw firm conclusions.

Key Takeaways

  • The endocannabinoid system is already wired into exercise — anandamide levels rise during sustained cardio and likely contribute to the "runner's high"
  • THC can make workouts feel easier by lowering perceived exertion, but that doesn't translate to better actual performance in most measurable areas
  • Cannabis raises your heart rate by 20 to 50 beats per minute on its own, so stacking that on top of exercise-induced heart rate elevation adds real cardiovascular stress — especially if you have an underlying heart condition
  • THC impairs coordination, reaction time, and balance, which makes activities that require precision or take place in traffic meaningfully more dangerous
  • Cannabinoids have anti-inflammatory and pain-relieving properties that could theoretically help with recovery, but clinical evidence specific to exercise recovery is still very thin
  • A 2019 University of Colorado study found that people who used cannabis around their workouts logged more weekly exercise minutes than non-users — suggesting the main benefit may be that it makes exercise more enjoyable, not that it makes you perform better

The Endocannabinoid System and Exercise

Body / Physical

Working Out High: Benefits vs. Risks by Category

Perceived ExertionMixed
Benefit: Workouts feel easier and more enjoyable
Risk: May push past safe limits without realizing
Heart RateNegative
Benefit: None — adds +20-50 BPM on top of exercise
Risk: Extra cardiovascular stress, especially with conditions
Coordination / BalanceNegative
Benefit: None
Risk: Impaired proprioception increases injury risk
Inflammation / RecoveryUnclear
Benefit: Anti-inflammatory properties may help soreness
Risk: Post-workout inflammation is needed for adaptation
Enjoyment / AdherencePositive
Benefit: More exercise minutes logged per week (CU Boulder)
Risk: May become dependent on THC to enjoy exercise
Endocannabinoid SystemUnknown
Benefit: Exercise naturally raises anandamide levels
Risk: Exogenous THC may disrupt natural ECS response
Sparling et al. (2015) • CU Boulder (2019)Working Out High: Benefits vs Risks

The endocannabinoid system (ECS) is not a passive bystander during exercise. It is actively involved. During sustained aerobic activity, the body produces elevated levels of endocannabinoids, particularly anandamide (AEA) and 2-arachidonoylglycerol (2-AG). These molecules bind to CB1 and CB2 receptors throughout the body and brain, modulating pain perception, mood, inflammation, and reward.

A 2003 study by Sparling and colleagues, published in NeuroReport, was among the first to document that blood levels of anandamide increase significantly after moderate-intensity aerobic exercise. This finding was expanded by Fuss and colleagues in a landmark 2015 PNAS study demonstrating that the "runner's high," long attributed to endorphins, is actually mediated primarily by endocannabinoids. Endorphins are too large to cross the blood-brain barrier efficiently. Endocannabinoids are not.

This means the ECS is already deeply integrated into the exercise experience. When you run, swim, or cycle at sustained intensity, your body naturally floods itself with cannabinoid-like molecules that reduce pain, elevate mood, and promote a sense of well-being. The exercise high is, in a very real sense, a cannabinoid high.

THC as an Exogenous Cannabinoid During Exercise

THC is an exogenous cannabinoid. It activates the same CB1 receptors that anandamide activates during exercise. This raises a straightforward question: does adding THC to the system amplify the natural exercise response, replace it, or interfere with it?

The honest answer is that we do not know with certainty. The research on acute THC administration during exercise is remarkably thin. Most of what we can say comes from combining what we know about THC's general physiological effects with what we know about exercise physiology.

What we can say with reasonable confidence is the following.

Heart rate. THC acutely increases resting heart rate by approximately 20 to 50 beats per minute through sympathetic nervous system activation. Exercise also elevates heart rate. The combination produces an additive effect, meaning your heart rate during exercise while high will be meaningfully higher than during the same exercise sober. For a healthy 25-year-old, this may be inconsequential. For someone with an underlying cardiovascular condition, undiagnosed arrhythmia, or significant deconditioning, the added cardiovascular stress is a genuine safety concern.

Perceived exertion. Multiple user reports and a small number of studies suggest that THC reduces perceived exertion during exercise. A workout that would normally feel difficult feels more manageable. This effect likely operates through both pain modulation (THC is an analgesic) and mood elevation. The practical implication is that people may exercise longer or at higher intensities than they would sober. Whether this is beneficial (because they do more work) or risky (because they exceed their safe capacity without recognizing it) depends on the context.

Coordination and reaction time. THC consistently impairs fine motor coordination, reaction time, and balance in controlled studies. These impairments are dose-dependent but present even at modest doses. For activities like weightlifting with a barbell, trail running, cycling in traffic, or any sport requiring quick reactions, impaired coordination introduces real injury risk. For activities like walking on a treadmill or riding a stationary bike, the risk is lower.

What Elite Athletes Report vs. What Research Shows

Several high-profile athletes have spoken publicly about cannabis use in relation to their training. Former NFL players have described using cannabis for pain management and recovery. Ultra-runners and trail athletes in legal states have described using small amounts before long training runs. MMA fighters have discussed cannabis as part of their recovery protocols.

These testimonials are real, but they are not evidence. They suffer from the same limitations as all anecdotal reports: survivorship bias (we hear from athletes who had good experiences, not those who got injured or saw performance decline), inability to control for other variables, and the placebo-adjacent effect of believing something works.

The controlled research that does exist does not support performance enhancement from THC. A 1986 study by Steadward and Singh found that cannabis did not improve and slightly impaired aerobic performance. The World Anti-Doping Agency (WADA) prohibits cannabis in competition, though the threshold was raised in 2013, and the rationale for the ban has been debated. The evidence for cannabis as a genuine performance-enhancing drug is weak. The more accurate framing is that cannabis may alter the experience of exercise without improving the output.

For a deeper look at what professional athletes actually report and how it maps to the evidence, see athletes, cannabis, performance, and recovery.

Perceived Exertion: The Central Finding

If there is one area where cannabis might have a legitimate positive interaction with exercise, it is the reduction of perceived exertion. This effect has been reported consistently enough across user surveys to take seriously, even though the controlled trial evidence is limited.

The mechanism likely involves multiple pathways. THC is a partial agonist at CB1 receptors in the anterior cingulate cortex and insula, brain regions involved in processing how effortful and unpleasant physical activity feels. By dampening these signals, THC may lower the psychological barrier to sustained exertion. Separately, THC's analgesic effects may reduce the pain signals that accumulate during intense exercise, making the physical discomfort more tolerable.

For people who struggle with exercise adherence, particularly those who find physical activity genuinely unpleasant, this effect could theoretically improve consistency. A 2019 survey by YorkWilliams and colleagues found that cannabis users who exercised with cannabis reported more weekly exercise minutes than those who did not. The authors proposed that increased enjoyment was the mediating factor.

However, this comes with a significant caveat. Reduced perceived exertion does not mean reduced physiological stress. Your muscles, joints, and cardiovascular system are still experiencing the same workload. If cannabis causes you to exceed your safe capacity because the warning signals are muted, the result could be overtraining, injury, or cardiovascular events. The pain and discomfort of exercise exist for a reason.

Pain Modulation and Recovery

The anti-inflammatory properties of cannabinoids are well-documented in preclinical research. Both THC and CBD interact with immune pathways that regulate inflammation. Exercise, particularly intense or novel exercise, produces an inflammatory response as part of the muscle repair and adaptation process. The question is whether modulating that inflammation with cannabinoids helps or hinders recovery.

The answer is not straightforward. Acute inflammation after exercise is actually necessary for adaptation. It signals the body to repair damaged tissue and build stronger structures. Chronically suppressing post-exercise inflammation (which is the same concern raised about regular NSAID use after workouts) could theoretically blunt the adaptive response to training.

On the other hand, excessive inflammation contributes to prolonged soreness and delayed recovery. For athletes training multiple times per day or dealing with chronic overuse injuries, reducing excessive inflammation could be beneficial.

The problem is that we have almost no clinical data specific to cannabinoids and exercise recovery. The theoretical arguments are plausible in both directions. What exists is mostly extrapolation from general anti-inflammatory research and athlete testimonials. Treating cannabinoids as a proven recovery tool based on current evidence is premature.

Safety Concerns Worth Taking Seriously

Several safety issues deserve direct attention.

Cardiovascular risk. The additive effect of THC and exercise on heart rate has been discussed, but it bears repeating. Case reports exist of acute cardiovascular events (including myocardial infarction) triggered by cannabis use combined with physical exertion, particularly in individuals with undiagnosed heart conditions. This is rare but not theoretical.

Impaired coordination and injury risk. Any exercise involving heavy weights, complex movements, balance, or environmental hazards (traffic, trails, water) becomes more dangerous with impaired coordination. A missed step on a trail run or a failed barbell lift can produce serious injury. The impairment from THC is subtle enough that users often do not recognize it, which compounds the problem.

Bronchial irritation. Smoking cannabis before exercise introduces hot, particulate-laden smoke into airways that are about to demand peak gas exchange performance. This is counterproductive from a respiratory standpoint. Vaporizing or edibles avoid this specific issue but introduce their own considerations (edibles have delayed, unpredictable onset that is poorly suited to exercise timing).

Heat regulation. Limited evidence suggests cannabinoids may affect thermoregulation. Exercising in heat while using cannabis could theoretically increase the risk of heat-related illness, though this has not been studied systematically.

Dose, Method, and Context Matter Enormously

If there is one theme that runs through all cannabis research, it is that the details matter. A single low-dose vaporized inhalation 30 minutes before a treadmill walk is a fundamentally different exposure than consuming a high-THC edible before a heavy deadlift session. The dose, the method of consumption, the type of exercise, the environment, and the individual's tolerance all modulate the effects.

Most people who report positive experiences with cannabis and exercise describe using low doses of moderate-potency products before low-risk, moderate-intensity activities, often solo or in safe environments. This is a different profile from the stereotypical image of getting heavily stoned before a workout.

What the Evidence Supports, Honestly

Cannabis does not appear to enhance exercise performance by any objective measure. It does appear to alter the subjective experience of exercise in ways that some people find beneficial, primarily through reduced perceived exertion and increased enjoyment. It carries real safety risks related to cardiovascular stress, impaired coordination, and the masking of important physiological signals.

The endocannabinoid system is genuinely central to exercise physiology, and the theoretical basis for interactions between exogenous cannabinoids and exercise is sound. But the controlled clinical research is minimal. Most of what we believe about cannabis and exercise is extrapolated from adjacent research domains or derived from self-report surveys, which are vulnerable to expectancy effects and recall bias.

For people who choose to combine cannabis and exercise, the evidence suggests keeping the dose low, choosing lower-risk activities, avoiding environments where impaired coordination creates danger, and being honest about whether the cannabis is actually improving the experience or simply making it easier to avoid noticing problems. The ECS is already doing remarkable things during exercise. Whether supplementing it with THC adds value, adds risk, or simply changes the character of the experience is a question the research has not yet definitively answered.

The Bottom Line

Evidence review of cannabis and exercise covering ECS exercise physiology, perceived exertion, performance data, recovery, and safety. ECS in exercise: Sparling 2003 NeuroReport — anandamide rises during sustained aerobic activity; Fuss 2015 PNAS — runner's high mediated by endocannabinoids not endorphins (CB1 knockout blocked anxiety/pain reduction, opioid blockade did not). THC during exercise: heart rate additive (THC 20-50 bpm + exercise elevation); perceived exertion reduced (CB1 in anterior cingulate cortex/insula + analgesic effects); coordination/reaction time impaired (cerebellar CB1). Performance: Steadward and Singh 1986 — cannabis did not improve, slightly impaired aerobic performance; no VO2 max improvement in any study; WADA prohibits in-competition. Perceived exertion: YorkWilliams 2019 — cannabis users who co-used reported more weekly exercise minutes; enjoyment as mediating factor; reduced exertion ≠ reduced physiological stress. Recovery: THC/CBD anti-inflammatory properties theoretically relevant but acute post-exercise inflammation necessary for adaptation; no clinical data specific to cannabinoid exercise recovery. Safety: cardiovascular stress (additive HR, case reports of MI during exercise + cannabis), impaired coordination (weights, trails, traffic), bronchial irritation from smoking, thermoregulation concerns, pain masking (push through injury signals). Evidence-based: cannabis may alter exercise experience without improving output; keep doses low, choose low-risk activities, avoid environmental hazards.

Frequently Asked Questions

Sources & References

  1. 1RTHC-06444·Feinberg, Steven D et al. (2025). Occupational medicine guideline says cannabis is not recommended for common workplace injuries and conditions.” Journal of occupational and environmental medicine.Study breakdown →PubMed →
  2. 2RTHC-07874·Vikingsson, Svante et al. (2025). Legal CBD Products With Trace THC Can Cause Positive Drug Tests in Oral Fluid.” Journal of analytical toxicology.Study breakdown →PubMed →
  3. 3RTHC-05832·Yang, Kevin H et al. (2024). Cannabis Use and Cannabis Use Disorder Linked to More Missed Work Days in National Survey.” American journal of preventive medicine.Study breakdown →PubMed →
  4. 4RTHC-04218·Sholler, Dennis J et al. (2022). Oral cannabis produced higher urine drug test concentrations than vaporized cannabis.” Journal of analytical toxicology.Study breakdown →PubMed →
  5. 5RTHC-04024·MacCallum, Caroline A et al. (2022). A Clinical Framework for Assessing Cannabis Impairment Risk in Patients.” Frontiers in psychiatry.Study breakdown →PubMed →
  6. 6RTHC-01228·Molnar, Anna et al. (2016). How Sativex Complicates Drug Testing: A Review of THC Detection Methods Across Blood, Urine, Saliva, and Hair.” Bioanalysis.Study breakdown →PubMed →
  7. 7RTHC-05003·Vikingsson, Svante et al. (2023). Delta-8 THC Is Already Showing Up in 1 in 4 Positive Workplace Drug Tests.” Journal of analytical toxicology.Study breakdown →PubMed →
  8. 8RTHC-03836·Feltmann, Kristin et al. (2022). Swedish Workplace Drug Tests Over 25 Years: Positive Results Quadrupled, With Cannabis Driving the Recent Surge.” European journal of public health.Study breakdown →PubMed →

Research Behind This Article

Showing the 8 most relevant studies from our research database.

Strong EvidenceCross-Sectional

Cannabis Use, Use Disorder, and Workplace Absenteeism in the U.S., 2021-2022.

Yang, Kevin H · 2024

Past-month cannabis use was associated with more missed work days due to illness and more skipped work days compared to no lifetime use.

Strong EvidenceReview

Cannabis.

Feinberg, Steven D · 2025

Some evidence for MS spasticity, but no quality evidence for back pain, radiculopathy, neuropathic pain, or other common work-related pain.

Strong Evidenceclinical-trial

The Acute and Chronic Pharmacokinetic Oral Fluid Profile of Oral Cannabidiol (CBD) With and Without Low Doses of Delta-9-Tetrahydrocannabinol (Δ9-THC) in Healthy Human Volunteers.

Vikingsson, Svante · 2025

After taking 100 mg CBD with just 0.5 mg THC (well within legal hemp limits), 1 in 10 participants tested positive for THC in oral fluid.

Moderate EvidenceRandomized Controlled Trial

Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.

Sholler, Dennis J · 2022

Using federal workplace drug-testing criteria (50 ng/mL screening, 15 ng/mL confirmation), urine specimens tested positive for THC-COOH in 97.6% of oral cannabis sessions versus 59.5% of vaporized sessions at active THC doses..

Moderate EvidenceLongitudinal Cohort

Workplace and non-workplace cannabis use and the risk of workplace injury: Findings from a longitudinal study of Canadian workers.

Carnide, Nancy · 2023

Among 2,745 Canadian workers followed from 2018-2020, workplace cannabis use (before or at work) was associated with a nearly two-fold increased risk of workplace injury (RR 1.97, 95% CI 1.32-2.93).

Moderate EvidenceCross-Sectional

Association of Physical Activity, Sedentary Behavior, and Cannabis Use: A Cross-Sectional Study.

Dai, Jinming · 2026

After adjusting for covariates, sedentary behavior was positively associated with cannabis use (OR=1.365), as were work physical activity (OR=1.135) and commuting activity (OR=1.209).

Moderate EvidenceCross-Sectional

Workplace Drug Testing-Prevalence of Positive Test Results, Most Common Substances, and Importance of Medical Review.

Helander, Anders · 2025

This analysis of 23,900 workplace drug test results from Sweden provides a snapshot of substance use among employed people.

Moderate EvidenceCross-Sectional

Cross-sectional analysis of cannabis use at work in the USA: differences by occupational risk level and state-level cannabis laws.

Kucera, Ava · 2025

Workplace use highest in recreational states (8.5%) vs.